74 related articles for article (PubMed ID: 22451061)
21. The effect of miR-7 on behavior and global protein expression in glioma cell lines.
Lu ZJ; Liu SY; Yao YQ; Zhou YJ; Zhang S; Dai L; Tian HW; Zhou Y; Deng HX; Yang JL; Luo F
Electrophoresis; 2011 Dec; 32(24):3612-20. PubMed ID: 22120825
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
23. Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level.
Chen S; Wang H; Ng WL; Curran WJ; Wang Y
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1524-9. PubMed ID: 22014955
[TBL] [Abstract][Full Text] [Related]
24. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
Cho WC; Chow AS; Au JS
Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
[TBL] [Abstract][Full Text] [Related]
25. Protein expression in human non-small cell lung cancer: a systematic database.
Bührens RI; Amelung JT; Reymond MA; Beshay M
Pathobiology; 2009; 76(6):277-85. PubMed ID: 19955839
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of the human urinary proteome by 1D SDS-PAGE and chip-HPLC-MS/MS identification of the AACT putative urinary biomarker.
Zhang Y; Li Y; Qiu F; Qiu Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3395-401. PubMed ID: 21093387
[TBL] [Abstract][Full Text] [Related]
27. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.
Hofmann HS; Bartling B; Simm A; Murray R; Aziz N; Hansen G; Silber RE; Burdach S
Oncol Rep; 2006 Sep; 16(3):587-95. PubMed ID: 16865260
[TBL] [Abstract][Full Text] [Related]
28. Proteomic signature of human cancer cells.
Seike M; Kondo T; Fujii K; Yamada T; Gemma A; Kudoh S; Hirohashi S
Proteomics; 2004 Sep; 4(9):2776-88. PubMed ID: 15352251
[TBL] [Abstract][Full Text] [Related]
29. microRNA-145 suppresses lung adenocarcinoma-initiating cell proliferation by targeting OCT4.
Yin R; Zhang S; Wu Y; Fan X; Jiang F; Zhang Z; Feng D; Guo X; Xu L
Oncol Rep; 2011 Jun; 25(6):1747-54. PubMed ID: 21479367
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
31. Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures.
Wei Y; Tong J; Taylor P; Strumpf D; Ignatchenko V; Pham NA; Yanagawa N; Liu G; Jurisica I; Shepherd FA; Tsao MS; Kislinger T; Moran MF
J Proteome Res; 2011 Jan; 10(1):161-74. PubMed ID: 20815376
[TBL] [Abstract][Full Text] [Related]
32. Proteomic profiling of human pleural effusion using two-dimensional nano liquid chromatography tandem mass spectrometry.
Tyan YC; Wu HY; Lai WW; Su WC; Liao PC
J Proteome Res; 2005; 4(4):1274-86. PubMed ID: 16083277
[TBL] [Abstract][Full Text] [Related]
33. Quantitative proteomics and protein network analysis of A549 lung cancer cells affected by miR-206.
Cui Y; Xie S; Luan J; Zhou X; Han J
Biosci Trends; 2013 Dec; 7(6):259-63. PubMed ID: 24390363
[TBL] [Abstract][Full Text] [Related]
34. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.
Gallardo E; Navarro A; Viñolas N; Marrades RM; Diaz T; Gel B; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
Carcinogenesis; 2009 Nov; 30(11):1903-9. PubMed ID: 19736307
[TBL] [Abstract][Full Text] [Related]
35. [Comparative proteomic analysis of human large cell lung cancer cell line with high and low metastasis potentials].
Gao LW; Zhu W; Feng ZH; An N
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):706-10. PubMed ID: 19024295
[TBL] [Abstract][Full Text] [Related]
36. The expression and function of miRNA-451 in non-small cell lung cancer.
Wang XC; Tian LL; Jiang XY; Wang YY; Li DG; She Y; Chang JH; Meng AM
Cancer Lett; 2011 Dec; 311(2):203-9. PubMed ID: 21875770
[TBL] [Abstract][Full Text] [Related]
37. S100A2 induces metastasis in non-small cell lung cancer.
Bulk E; Sargin B; Krug U; Hascher A; Jun Y; Knop M; Kerkhoff C; Gerke V; Liersch R; Mesters RM; Hotfilder M; Marra A; Koschmieder S; Dugas M; Berdel WE; Serve H; Müller-Tidow C
Clin Cancer Res; 2009 Jan; 15(1):22-9. PubMed ID: 19118029
[TBL] [Abstract][Full Text] [Related]
38. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
Bandi N; Zbinden S; Gugger M; Arnold M; Kocher V; Hasan L; Kappeler A; Brunner T; Vassella E
Cancer Res; 2009 Jul; 69(13):5553-9. PubMed ID: 19549910
[TBL] [Abstract][Full Text] [Related]
39. Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches.
Zhang W; Wei Y; Ignatchenko V; Li L; Sakashita S; Pham NA; Taylor P; Tsao MS; Kislinger T; Moran MF
Proteomics; 2014 Mar; 14(6):795-803. PubMed ID: 24453208
[TBL] [Abstract][Full Text] [Related]
40. Proteomic identification of target proteins following Drosha knockdown in cervical cancer.
Zhou J; Cai J; Huang Z; Ding H; Wang J; Jia J; Zhao Y; Huang D; Wang Z
Oncol Rep; 2013 Nov; 30(5):2229-37. PubMed ID: 23969986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
